
    
      This is a non-randomized, prospective, multi-center safety and device success study. 34
      patients have been enrolled at 4 participating investigational centers in Europe. Patient
      participation will last for a minimum of 5 years. Patients will be assessed at the following
      intervals: baseline, discharge, 30 days, 6 months, 1 year and annually thereafter through 5
      years
    
  